Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Clinical Trials in Turkey / NCT06776718
Starting soon Not applicable

VNOTES and Vaginal Hysterectomy for Benign Indications

NCT06776718 · tracked via the Priya Life Science Turkey tracker
Sponsor
Dr. Lutfi Kirdar Kartal Training and Research Hospital
Phase
Not applicable
Started
2025-01
Last updated
2025-01-15

Condition(s) studied

HysterectomyHysterectomy, Benign Uterine DiseasesHysterectomy, Vaginal

Investigational drug(s) / intervention(s)

vNOTESvaginal hysterectomy

vNOTES: vNOTES for benign hysterectomy

vaginal hysterectomy: vaginal hysterectomy for benign hysterectomy

Study summary

This study aimed to compare the surgical outcomes of Vaginal Natural Orifice Transluminal Endoscopic Surgery (vNOTES) and conventional vaginal hysterectomy (VH) for benign gynecological conditions.

A prospective analysis will conducted at a tertiary hospital from January 2025 to February 2025. Patients aged 40-80 who underwent hysterectomy for benign indications will included. Outcomes will assessed included surgical outcomes, Visual Analog Scale (VAS) pain scores, and complication rates.

Eligibility

Sex
FEMALE
Min age
40 Years
Max age
80 Years
Healthy volunteers
No
Inclusion Criteria: * aged between 40 and 80 years * undergo hysterectomy for benign gynecological conditions Exclusion Criteria: * history of urogynecological surgery (including pelvic organ prolapse surgery and mid-urethral sling procedures), * suspected gynecologic malignancies, * endometriosis, * tubal-ovarian abscesses, * pelvic organ prolapse exceeding grade 2, * individuals who refused to participate in the study

Primary outcome measure(s)

  • the duration of surgery — The time from the beginning to the end of the operation
    İnterval from initial incision to the completion of vaginal cuff closure (minute)

Trial sites (1)

FacilityCityRegionStatus
Kartal Dr Lütfi Kirdar City Hospital Istanbul Turkey (Türkiye)

More Dr. Lutfi Kirdar Kartal Training and Research Hospital trials in Turkey

Investigation of the Effect of Hyperbaric Oxygen Therapy in Patients With Avascular Necrosis Active, not recruiting
Comparison of Video Based Phone App vs. Supervised Preoperative Exercise for ACL Reconstruction Recruiting
The Effect of Nutritional Status on Postoperative Mortality and Morbidity in the Geriatric Population Undergoing Gastrointestinal Surgery Active, not recruiting
Dual-Modality Immunotherapy for HPV Clearance (DUAL-HPV) Active, not recruiting
Effect of an Intraoperative Polynucleotide Injection on Scar Quality After Thyroidectomy Starting soon

Other trials for the same condition

Effect of Abdominal Ice Pack After vNOTES Hysterectomy Enrolling by invitation
vNOTES Versus Vaginal Hysterectomy for Benign Gynecologic Indications Recruiting
Effectiveness of Thoracoabdominal Nerve Block (M-TAPA) on Postoperative Pain Relief in Laparoscopic Hysterectomy Recruiting
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06776718 on ClinicalTrials.gov ↗ ← All trials in Turkey